Frequently discussed combinations presented with transparent regular pricing, bundle pricing, savings, and the research pathways that connect them.
Bundle pages explain research context and product pricing. They do not provide multi-compound dosing schedules.
Retatrutide 20 mg · MOTS-C · 5-Amino-1MQ
Different metabolic pathways: incretin signaling, mitochondrial signaling, and NNMT research.
Frequently discussed together for educational research context. This is not a dosing recommendation or established combination therapy.
Wolverine · KLOW
A frequently discussed pairing centered on tissue-repair and inflammatory-pathway research.
Frequently discussed together for educational research context. This is not a dosing recommendation or established combination therapy.
NAD+ · MOTS-C · 5-Amino-1MQ
Connects NAD+ biology, mitochondrial signaling, and NNMT pathway research.
Frequently discussed together for educational research context. This is not a dosing recommendation or established combination therapy.
GHK-Cu · AHK-Cu
Two copper-peptide research profiles grouped for skin, matrix, scalp, and hair biology.
Frequently discussed together for educational research context. This is not a dosing recommendation or established combination therapy.
Tesamorelin · CJC-1295 / Ipamorelin
Compares GHRH-receptor research with a dual-pathway secretagogue blend.
Frequently discussed together for educational research context. This is not a dosing recommendation or established combination therapy.
Retatrutide 20 mg · KLOW · MOTS-C · NAD+ · 5-Amino-1MQ
A five-product collection spanning metabolic, recovery, mitochondrial, and cellular-energy research.
Frequently discussed together for educational research context. This is not a dosing recommendation or established combination therapy.
SS-31 · MOTS-C · NAD+
Separates an FDA-approved narrow SS-31 indication from investigational mitochondrial and cellular-energy research. The combination itself is not clinically validated.
Pricing will be published when inventory and documentation are finalized.
Tesamorelin + Ipamorelin
Compares GHRH-receptor and ghrelin-receptor signaling while clearly labeling the lack of validated combination evidence.
Selank · Semax
Stress-response, cognition, and neuroprotection research with prominent evidence limitations and no treatment claims.
Kisspeptin
A dedicated male and female research program covering GnRH signaling, fertility research, sexual-behavior studies, and desensitization.
ARA-290
Human neuropathy research separated from broader, unproven recovery claims.
